1. The Future of Antisense Oligonucleotides in the Treatment of Respiratory Diseases

   • Marina Ulanova
   • Alan D. Schreiber
   • A. Dean Befus

   Current Opinion 13 August 2012 Pages: 1 - 11

   

2. Mechanistic Rationale and Clinical Evidence for the Efficacy of Proteasome Inhibitors against Indolent and Mantle Cell Lymphomas

   • Luca Paoluzzi
   • Owen A. O’Connor

   Mechanisms and Targets 13 August 2012 Pages: 13 - 23

   

3. Understanding and Applying Regulatory Guidance on the Nonclinical Development of Biotechnology-Derived Pharmaceuticals

   • David J. Snodin
   • Peter R. Ryle

   Regulatory Issues 13 August 2012 Pages: 25 - 52

   

4. Abatacept

   • Pauline S. Hervey
   • Susan J. Keam

   Adis Drug Profile 13 August 2012 Pages: 53 - 61

   

5. Abatacept

   • Maxime Dougados

   Adis Drug Profile 13 August 2012 Pages: 62 - 62

6. Abatacept

   • Paul Emery

   Adis Drug Profile 13 August 2012 Pages: 62 - 62

7. Spotlight on Eptifibatide in Patients with Acute Coronary Syndromes and/or Undergoing Percutaneous Coronary Intervention

   • Monique P. Curran
   • Gillian M. Keating

   Adis Spotlight 13 August 2012 Pages: 63 - 65

8. Spotlight on Infliximab in Crohn Disease and Rheumatoid Arthritis

   • M. Asif A. Siddiqui
   • Lesley J. Scott

   Adis Spotlight 13 August 2012 Pages: 67 - 70